Abstract
Genome-wide association studies of physical activity traits have mapped numerous loci, yet the molecular mechanisms through which exercise influences human biology remain poorly defined. Mechanistic progress has been limited by heritability-dominated signals, siloed single-omic analyses, and the lack of integrative models that connect genetic associations to causal, system-level pathways. We introduce the first deep learning, multi-omic framework for exercise genomics, unifying causal inference, molecular topology, protein structure, and functional context within a supervised Graph Neural Network (GNN) with experimental validation. Using linkage disequilibrium-aware Mendelian randomisation with accelerometer-derived vigorous physical activity as the exposure, we integrated four omic layers—plasma proteomics, blood CpG methylation, blood single-cell transcriptomics, and plasma glycomics. The GNN prioritised a coherent, multi-omic network of exercise-responsive genes spanning glycosylation and immunity, apoptosis/stress signalling, growth and transcription factors, proteostasis/autophagy, metabolism, oxidative stress/redox, mitochondrial/oxidative phosphorylation, chromatin/epigenetic, translation/ribosome, RNA splicing/processing, DNA damage and repair, cell cycle, and cytoskeleton/ECM functions. Pathway annotation and alignment with ageing biology using differentially methylated regions and principal component features from five biological ageing clocks (Horvath, Hannum, DunedinPACE, PhenoAge, Proteomic Clock), used as contextual markers of ageing-related regulation, mapped to: 1) autophagy (Fas signalling); 2) stress and DNA damage response pathways (Hypoxia-Inducible Factor, apoptosis, p53, p38, PI3K, Ras, oxidative stress, DNA replication, purine/pyrimidine metabolism and biosynthesis, pentose phosphate, Rho GTPase, G protein, ubiquitin proteasome, Epidermal Growth Factor Receptor); 3) immune and inflammatory pathways (cytokine and interleukin signalling, T and B cell activation, Toll-like receptor signalling); 4) physiological adaptation (VEGF, Wnt, GnRH, Fibroblast Growth Factor, Platelet-Derived Growth Factor, Thyrotropin-Releasing Hormone, glutamate receptor, plasminogen, endothelin, heme biosynthesis, cholecystokinin, Corticotropin-Releasing Hormone signalling); 5) neuroendocrine and neurotransmitter pathways (acetylcholine, dopamine, oxytocin, opioid, β-adrenergic signalling); 6) neurodegeneration pathways (Alzheimer’s, Parkinson’s, Huntington’s disease); 7) protein metabolism (leucine, isoleucine, valine biosynthesis); and exercise-responsive epigenetic regulatory pathways (S-adenosylmethionine, thiamine, vitamin D biosynthesis, bZIP transcription, and circadian rhythm). Finally, we partially validated GNN predictions in humans, demonstrating acute exercise-induced shifts in plasma glycomic markers consistent with GNN-predicted glycomic remodelling. This work establishes a deep learning, multi-omic map of exercise-responsive pathways in humans and identifies actionable regulators that couple habitual vigorous physical activity to stress-resilient immunometabolic regulation and healthy ageing trajectories.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Protocols
https://www.isrctn.com/ISRCTN34136514
Funding Statement
This study did not receive any funding.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Graphical abstract added. Discussion expanded.
Data availability
Supplementary files are available at https://github.com/cgjuan01
